PDCD1 and lung adenocarcinoma: Lucia Bonomi et al also reported of a case of stage 4 lung adenocarcinoma on treatment with nivolumab, anti PD‐1 (programmed cell death 1) agent, for 5 years having stable disease who died of COVID‐19 within 5 days of diagnosis.74